These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31000849)

  • 21. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
    Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
    Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing diabetes management through glucose profiling: a case-based approach.
    Streja DA
    Prim Care Diabetes; 2008 Dec; 2(4):167-73. PubMed ID: 18786873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20).
    van Hateren KJ; Landman GW; Kleefstra N; Drion I; Groenier KH; Houweling ST; Bilo HJ
    Int J Clin Pract; 2011 Apr; 65(4):415-9. PubMed ID: 21401830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
    Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.
    Ekström N; Miftaraj M; Svensson AM; Andersson Sundell K; Cederholm J; Zethelius B; Gudbjörnsdottir S; Eliasson B
    Diabetes Obes Metab; 2012 Aug; 14(8):717-26. PubMed ID: 22364580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycaemic control among patients with type 2 diabetes followed in a rural African primary care setting - A reality check in the Democratic Republic of Congo.
    Blum J; Chaney M; Mudji J; Mfungwa JK; Rice T; Labhardt ND
    Prim Care Diabetes; 2020 Apr; 14(2):139-146. PubMed ID: 31455548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary habits and practices of type-2 diabetic patients in a tertiary care centre of Islamabad, Pakistan.
    Farooq MU; Mushtaq F; Naeem Z; Iqbal S; Naseem S; Ishtiaq O
    J Pak Med Assoc; 2018 May; 68(5):825-830. PubMed ID: 29885196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of Albumin, Red Cell Distribution Width and Other Biochemical and Hematological Parameters with Glycated Hemoglobin in Diabetic, Prediabetic and Non-Diabetic Patients.
    Ginoudis A; Ioannidou S; Tsakiroglou G; Kazeli K; Vagdatli E; Lymperaki E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycated haemoglobin and glycaemic control of diabetics in Ilorin.
    Adebisi SA; Oghagbon EK; Akande TM; Olarinoye JK
    Niger J Clin Pract; 2009 Mar; 12(1):87-91. PubMed ID: 19562929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial.
    Maple-Brown LJ; Ye C; Retnakaran R
    Diabet Med; 2013 Jan; 30(1):95-9. PubMed ID: 22937915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycaemic control in native Kuwaiti Arab patients with type 2 diabetes.
    Channanath AM; AlWotayan R; Alkandari H; Davidsson L; Tuomilehto J; Thanaraj TA
    Prim Care Diabetes; 2018 Dec; 12(6):526-532. PubMed ID: 30115526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between glycaemic control and activation of the renin-angiotensin-aldosterone system in participants with type 2 diabetes mellitus and hypertension.
    Griffin TP; Wall D; Browne GA; Dennedy MC; O'Shea PM
    Ann Clin Biochem; 2018 May; 55(3):373-384. PubMed ID: 28814103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes.
    Yu PC; Bosnyak Z; Ceriello A
    Diabetes Res Clin Pract; 2010 Jul; 89(1):1-9. PubMed ID: 20494468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.